Precision Oncology News

Integrated Genomic Analysis Highlights Potential Strategy for Overcoming Some ALL Resistance

Mar 09, 2020

NEW YORK – Based on findings from an integrated genomic, transcriptomic, and epigenomic analysis of acute lymphoblastic leukemia (ALL) cases, a St. Jude Children's Research Hospital-led team has proposed a potential treatment alternative treatment for glucocorticoid steroid-resistant ALL patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Menu

Integrated Genomic Analysis Highlights Potential Strategy for Overcoming Some ALL Resistance

To read the full story....

Breaking News

Theseus Pharmaceuticals Emerges from Stealth Mode, Raises $100M in Series B Funding

BridgeBio Rolls Out New Academic Pacts to Advance Precision Oncology Programs

AACR Study of Eli Lilly's Retevmo Shows Anti-Tumor Activity Across Cancers

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

Keytruda, Hormone Therapy Combination Benefits Advanced Breast Cancer Subgroup in AACR Study

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Featured White Papers

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

CaTCH it if you can! CRISPRa-based Exploration of Therapy Resistant Cell Clones

Disparities in Precision Oncology: Identifying Barriers and Moving Toward Solutions

What's Popular?

With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients

Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers

Sponsorships